A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction
Peng Qian, Hong Tian, Yongkang Wang, Weisheng Lu, Ying Li, Teng Ma, Xiangdong Gao, Wenbing Yao
Topics & Concepts
Diabetic cardiomyopathyLipotoxicityInternal medicineEndocrinologyMedicineDiabetes mellitusCardiomyopathyAgonistOxidative stressAtrial natriuretic peptideReceptorHeart failureInsulin resistanceDiabetes Treatment and ManagementDiabetes Management and ResearchMetabolism, Diabetes, and Cancer